{"custom_id": "Candesartan-Citalopram-Fluphenazine-Histamine H1 receptor_8:zero_shot", "response": "REASON: The question describes a phenothiazine antipsychotic that inhibits a rhodopsin-like G-protein-coupled receptor involved in smooth muscle, cardiac, endothelial, and CNS signaling. This points to the dopamine D2 receptor, a well-known target of phenothiazines.\nANSWER: dopamine D2 receptor </s>"}
{"custom_id": "Lamotrigine-Oxaprozin-Sildenafil_4:zero_shot", "response": "REASON: The question describes a drug with specific structural features and its interaction with another drug through \u03c0-\u03c0 stacking. It asks for the name of the first drug. The description of the core structure and side chain helps identify the drug.\nANSWER: Apixaban </s>"}
{"custom_id": "Ranitidine-Sibutramine-Zolpidem_4:zero_shot", "response": "REASON: The question describes a drug with specific structural features (imidazopyridine core, methyl and benzyl substituents) and another molecule with a cyclobutyl ring and a 4-chlorophenyl group. These structural features suggest potential \u03c0-\u03c0 stacking interactions. \nANSWER: Zolpidem </s>"}
{"custom_id": "Cetirizine-Dipyridamole-Sildenafil-Zaleplon_2:zero_shot", "response": "REASON: The question describes a PDE5 inhibitor that causes hypotension when combined with nitrates. It also states that this PDE5 inhibitor interacts with a sedative-hypnotic drug resulting in apoplexy. The question asks for the name of the PDE5 inhibitor. \nANSWER: Sildenafil </s>"}
{"custom_id": "Alprazolam-Bumetanide-Fenofibrate-Modafinil_5:zero_shot", "response": "REASON: The question describes a specific drug core structure (\"sulfinyl-linked diphenylmethane core with an acetamide group\") and then details a characteristic interaction it has (\"aromatic \u03c0-\u03c0 stacking interaction\") with another molecule (\"fibrate derivative featuring isopropyl and phenoxy moieties\"). Drug names often contain information about their structure, and this description strongly suggests a known drug. \nANSWER: Celecoxib </s>"}
{"custom_id": "alendronic acid-Pyridostigmine_0:zero_shot", "response": "REASON: Both bisphosphonates and acetylcholinesterase inhibitors are associated with an increased risk of gastric inflammation. However, the question asks for the medication that is specifically associated with this risk when coadministered with the **other**. Since bisphosphonates and acetylcholinesterase inhibitors are both used for different conditions, it implies that the question is referring to the increased risk when one of these medications is coadministered with the **other**. Therefore, the answer should be the medication that is typically used in conjunction with the other to cause this adverse effect.\nANSWER: bisphosphonate </s>"}
{"custom_id": "Ketorolac-Oxaprozin_0:zero_shot", "response": "REASON: The question describes a medication that inhibits prostaglandin synthesis, leading to gastric inflammation when combined with another NSAID. This is a characteristic of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. Ibuprofen is a propionic acid derivative NSAID.\nANSWER: Ibuprofen </s>"}
{"custom_id": "Naproxen-Doxazosin-Alpha-1B adrenergic receptor_7:zero_shot", "response": "REASON: The question describes a drug that acts as an inverse agonist at a receptor with a known crystal structure. This suggests a well-studied drug-target interaction. The mention of \"quinazoline-class agent\" points towards a specific class of drugs.  The side effects listed (dizziness and hypotension) are common to drugs targeting the cardiovascular system. Combining these clues, the protein targeted is likely a receptor involved in blood pressure regulation.\nANSWER: Angiotensin II receptor 2 (AGTR2) \n"}
{"custom_id": "Chloroquine-hydroxychloroquine_3:zero_shot", "response": "REASON: The molecule with the additional -OH group (ethanol) can form more hydrogen bonds than the other molecule. Hydrogen bonding occurs when a hydrogen atom is covalently linked to a highly electronegative atom like oxygen. The oxygen atom in the ethanol group can act as a hydrogen bond donor and acceptor, forming more hydrogen bonds with interacting partners.\nANSWER: Ethanol \n"}
{"custom_id": "Amlodipine-Pamidronic acid-thiotepa_1:zero_shot", "response": "REASON: The question describes a drug-drug interaction where a calcium channel antagonist, when combined with a bisphosphonate, causes erythema. This reaction is also observed when the bisphosphonate is combined with an organophosphorus anti-cancer medication. Therefore, the anti-cancer medication involved in the second interaction is likely the organophosphorus drug. \nANSWER: organophosphorus anti-cancer medication </s>"}
{"custom_id": "Diazepam-Duloxetine-Acamprosate_4:zero_shot", "response": "REASON: The question describes a drug with specific functional groups (acetyl amide, sulfonic acid, three-carbon chain) and a compound with a thiophene ring, ether linkage, and naphthyl group. These structural details point to a specific drug-compound interaction. \nANSWER: Valsartan </s>"}
{"custom_id": "Tramadol-Exemestane_0:zero_shot", "response": "REASON: Aromatase inhibitors are often used in conjunction with other drugs for treating hormone-receptor-positive breast cancer. Certain drugs, particularly those that suppress the immune system, can increase the risk of pneumonia. \nANSWER: Imatinib </s>"}
{"custom_id": "Haloperidol-Muscarinic acetylcholine receptor M5_6:zero_shot", "response": "REASON: The question describes a G protein-coupled receptor activated by acetylcholine, leading to inhibition of adenylate cyclase and decreased protein kinase A activity. This is characteristic of the muscarinic acetylcholine receptor (mAChR), specifically the M1 subtype.  Butyrophenone antipsychotics are known to block dopamine receptors, and a specific butyrophenone antipsychotic associated with extrapyramidal side effects, QT prolongation, and used to treat schizophrenia is haloperidol. Haloperidol directly binds and inhibits the dopamine D2 receptor, which is a G protein-coupled receptor. However, the question asks for a receptor inhibited by a butyrophenone antipsychotic, and the M1 receptor is not directly inhibited by"}
{"custom_id": "Alprazolam-Ciclopirox_3:zero_shot", "response": "REASON: The question describes a drug with a specific chemical structure (triazolobenzodiazepine fused to a chlorinated aromatic ring) and mentions its potential interaction with a molecule containing a cyclohexylpyridone structure. The question focuses on the hydrogen bonding aspect of this interaction. Drugs containing triazolobenzodiazepine cores are known for their anxiolytic and sedative properties.  \nANSWER: Xanax \n"}
{"custom_id": "Norfloxacin-Zolpidem-vincristine-Torasemide_2:zero_shot", "response": "REASON: The loop diuretic is likely interacting with the mitotic inhibitor by increasing its plasma concentration. Both drugs are primarily eliminated by renal excretion. Thus, the loop diuretic could reduce the renal clearance of the mitotic inhibitor, leading to higher drug levels and increased toxicity. \nANSWER: Furosemide (a loop diuretic) \n"}
{"custom_id": "Naproxen-Ondansetron-Salmeterol-Beta-1 adrenergic receptor_8:zero_shot", "response": "REASON: The question describes a long-acting bronchodilator used in asthma and COPD, delivered by dry-powder inhaler, which can cause cholecystitis when taken with a 5-HT3 receptor antagonist. This points to **salmeterol**, a common long-acting beta-agonist (LABA) with significant cardiac effects.  The LABA mechanism involves binding to and activating beta-2 adrenergic receptors in the lungs and beta-1 adrenergic receptors in the heart.\nANSWER: beta-1 adrenergic receptor \n"}
{"custom_id": "Cetirizine-Temozolomide_0:zero_shot", "response": "REASON: The question describes a specific antihistamine that causes erythema when combined with an alkylating agent. This suggests a drug-drug interaction. Among second-generation antihistamines, loratadine is known to have a low incidence of sedation and has been associated with erythema in combination with certain chemotherapy drugs, including alkylating agents. \nANSWER: loratadine </s>"}
{"custom_id": "Ziprasidone-Acamprosate_3:zero_shot", "response": "REASON: Both indolinone-fused benzothiazoles and sulfonic acid-containing amides can act as hydrogen bond acceptors or donors.\nANSWER: indolinone-fused benzothiazole, sulfonic acid-containing amide </s>"}
{"custom_id": "Orphenadrine-Sumatriptan_0:zero_shot", "response": "REASON: The question mentions a drug used for acute migraine attacks, which is a serotonin receptor agonist. It also mentions erythema as a potential adverse reaction.  Serotonin receptor agonists, particularly 5-HT1B/1D receptor agonists, are known to cause erythema. Therefore, the question is looking for a drug that, when taken with a serotonin receptor agonist, may increase the risk of erythema. \nANSWER: Sumatriptan \n"}
{"custom_id": "Triazolam-Rosiglitazone-Bimatoprost_1:zero_shot", "response": "REASON: The question describes a thiazolidinedione, a class of drugs that act as PPAR\u03b3 agonists, being co-administered with a medication used for ophthalmic purposes. It then states this combination increases the risk of adenopathy. One such medication used for ophthalmic purposes is bimatoprost, which is a PPAR\u03b3 agonist. \nANSWER: bimatoprost </s>"}
{"custom_id": "Furosemide-melphalan_0:zero_shot", "response": "REASON: Loop diuretics can cause hypokalemia, which can predispose patients to cardiac arrhythmias, a common cause of exertional dyspnea. Alkylating agents can also cause myelosuppression, leading to anemia and further exacerbating exertional dyspnea. However, the combination of loop diuretics and alkylating agents is known to increase the risk of QT prolongation, a serious cardiac arrhythmia directly linked to exertional dyspnea. \nANSWER: Loop diuretic </s>"}
{"custom_id": "Fentanyl-desvenlafaxine_0:zero_shot", "response": "REASON: The question describes a potent synthetic opioid that is widely implicated in overdose scenarios. This suggests the drug is highly effective at suppressing the central nervous system. To cause \"nervous tension\" alongside this effect, another drug that either stimulates the nervous system or has paradoxical effects on the opioid could be the culprit. \nANSWER: Benzodiazepine \n"}
{"custom_id": "Alprazolam-Ciclopirox_0:zero_shot", "response": "REASON: The question describes a drug used for anxiety and mentions another drug that is an antifungal. It is known that some antifungals can lower blood pressure. Thus, the answer is likely the anxiety drug.\nANSWER: Xanax </s>"}
{"custom_id": "Temazepam-Zafirlukast_3:zero_shot", "response": "REASON: The drug described has structural features that suggest hydrogen bonding with a compound containing sulfonamide and carbamate groups. Sulfonamides and carbamates are known to participate in hydrogen bonding interactions. \nANSWER: Diazepam </s>"}
{"custom_id": "Ondansetron-Pirbuterol_0:zero_shot", "response": "REASON: The question describes a medication used for asthma that might interact with an antiemetic drug. It mentions \"short-acting \u03b22 agonist\" which points towards albuterol. Albuterol is indeed a bronchodilator often used for asthma. Serotonin 5-HT3 receptor antagonists are known for their antiemetic properties, with ondansetron being a common example. Ondansetron is frequently used in chemotherapy and postoperative settings. Loss of weight is a known side effect of ondansetron. Thus, ondansetron is the likely medication causing the weight loss interaction. \nANSWER: ondansetron </s>"}
{"custom_id": "Temazepam-Zafirlukast-Cysteinyl leukotriene receptor 1_7:zero_shot", "response": "REASON: The question describes a protein involved in allergic reactions that is inhibited by a medication used for asthma. Leukotrienes are known mediators of inflammation and bronchoconstriction, and a common asthma medication targets leukotriene receptors. \nANSWER: Leukotriene receptor \n"}
{"custom_id": "Temazepam-Megestrol-Desloratadine-Darunavir_2:zero_shot", "response": "REASON: The question describes a patient taking loratadine, an H1 inverse agonist, and develops pancreatitis after starting an antiretroviral protease inhibitor boosted with ritonavir or cobicistat. Literature suggests protease inhibitors can cause pancreatitis. \nANSWER: lopinavir/ritonavir </s>"}
{"custom_id": "Alprazolam-Benazepril_3:zero_shot", "response": "REASON: The triazolobenzodiazepine core with a chlorine substituent has more potential sites for hydrogen bond acceptance due to the presence of multiple nitrogen atoms and the electronegative chlorine atom.\nANSWER: triazolobenzodiazepine core with a chlorine substituent </s>"}
{"custom_id": "Diazepam-Doxazosin_3:zero_shot", "response": "REASON: The question describes a drug with a specific structure, highlighting a seven-membered diazepine ring fused to a benzene ring with a chlorine substituent. This structure is characteristic of Xanax. The second drug is described as having a quinazoline core with methoxy and dioxane-linked phenyl substituents, which matches the structure of Gefitinib. Drug-drug interactions involving \u03c0-\u03c0 stacking are common, and these two drugs have been known to interact. \nANSWER: Xanax, Gefitinib </s>"}
{"custom_id": "Risedronic acid-Imatinib_0:zero_shot", "response": "REASON: Bisphosphonates inhibit bone resorption by interfering with osteoclast activity. They are known to cause esophagitis, but not sinus headaches. ATP-competitive small molecule inhibitors targeting kinases involved in leukemic cell proliferation can cause a range of side effects, including headache. The question implies a side effect associated with the bisphosphonate, which is incorrect. \nANSWER: ATP-competitive small molecule inhibitor \n"}
{"custom_id": "Norfloxacin-Zolpidem_0:zero_shot", "response": "REASON: The question describes a fluoroquinolone antibiotic that interacts with a nonbenzodiazepine hypnotic to cause folate deficiency. Fluoroquinolones inhibit bacterial DNA gyrase and topoisomerase IV, while nonbenzodiazepine hypnotics act on GABA receptors. None of these directly relate to folate metabolism. However, the folate antagonist nature of sulfonamides, another class of antibiotics, is relevant. Sulfonamides, like fluoroquinolones, inhibit bacterial dihydropteroate synthase, an enzyme crucial for folate synthesis. Thus, the interaction likely involves the fluoroquinolone inhibiting bacterial folate synthesis, leading to increased systemic folate levels that are then shunted to the red blood cells, causing folate deficiency. \nANSWER:"}
{"custom_id": "Alprazolam-Bumetanide_0:zero_shot", "response": "REASON: The question describes a loop diuretic that causes erythema when combined with a benzodiazepine.  This is a known interaction between furosemide and benzodiazepines. \nANSWER: furosemide </s>"}
{"custom_id": "Celecoxib-Oxaprozin-Sildenafil_1:zero_shot", "response": "REASON: The question describes a drug used for erectile dysfunction and pulmonary arterial hypertension, which points to phosphodiesterase type 5 inhibitors like **Sildenafil**.  Combining Sildenafil with a propionic acid derivative NSAID is known to increase the risk of gastric inflammation. \nANSWER: Sildenafil \n"}
{"custom_id": "Rofecoxib-Telmisartan-solifenacin_4:zero_shot", "response": "REASON: The question describes a drug with a specific chemical structure and then details its interaction with an angiotensin II receptor antagonist, which is known to have multiple aromatic rings. This suggests a \u03c0-\u03c0 stacking interaction. A common drug with this structural description is a class of drugs used to treat hypertension.\nANSWER: Losartan </s>"}
{"custom_id": "Carvedilol-Darunavir_0:zero_shot", "response": "REASON: The adverse event describes a serious bleeding event (coughing up blood).  Nonselective beta-adrenergic blockers can cause bradycardia, which might lead to bleeding complications. Additionally, protease inhibitors are known to cause drug interactions, potentially leading to increased bleeding risk. Alpha-1 antagonists can also contribute to bleeding risk.\nANSWER: protease inhibitor </s>"}
{"custom_id": "Lidocaine-Pamidronic acid-thiotepa_1:zero_shot", "response": "REASON: The question describes a bisphosphonate used to treat osteoporosis and an organophosphorus anti-cancer agent that, when combined, increases the risk of erythema. It is unlikely that the bisphosphonate itself is causing this increased risk. Erythema is often a sign of inflammation or allergic reaction. Bisphosphonates are not known for causing significant inflammatory reactions. Therefore, the increased risk is likely due to an interaction between the bisphosphonate and the anti-cancer agent. The question provides the chemical formula of the anti-cancer agent, which can be used to identify it.\nANSWER: Tepadina \n"}
{"custom_id": "Loxapine-Histamine H1 receptor_6:zero_shot", "response": "REASON: The question describes a receptor that is inhibited by a tricyclic antipsychotic drug structurally similar to clozapine. Clozapine is known to bind to the dopamine D2 receptor, a rhodopsin-like G-protein-coupled receptor. Thus, the receptor described in the question is likely the dopamine D2 receptor. \nANSWER: dopamine D2 receptor \n"}
{"custom_id": "Carvedilol-Darunavir_3:zero_shot", "response": "REASON: Methoxyphenoxypropanolamine moieties are known to act as hydrogen bond donors due to the presence of the -NH2 group. Sulfonamide groups, while capable of acting as hydrogen bond acceptors, are less likely to be hydrogen bond donors.\nANSWER: Methoxyphenoxypropanolamine moiety </s>"}
{"custom_id": "Triazolam-Zaleplon_3:zero_shot", "response": "REASON: The question describes a specific triazolobenzodiazepine drug with two chlorine-substituted aromatic rings and a pyrazolopyrimidine derivative with a nitrile group and an N-ethylacetamide side chain. These structural features suggest a \u03c0-\u03c0 stacking interaction. \nANSWER: Alprazolam </s>"}
{"custom_id": "Fluorouracil-vincristine_3:zero_shot", "response": "REASON: The fluorinated aromatic ring fused to a pyrimidine dione scaffold is more likely to act as a hydrogen bond donor. Aromatic rings can act as hydrogen bond acceptors due to their electron-rich pi system, and the pyrimidine dione scaffold contains multiple nitrogen atoms capable of acting as hydrogen bond acceptors. The multi-ring alkaloid with multiple methoxy, carbonyl, and amine functions is more likely to act as a hydrogen bond acceptor.\nANSWER: Fluorinated aromatic ring fused to a pyrimidine dione scaffold </s>"}
{"custom_id": "Haloperidol-Histamine H1 receptor_6:zero_shot", "response": "REASON: The question describes a protein activated by histamine and involved in allergic responses. This points towards a histamine receptor. The question further specifies that this receptor is a member of the rhodopsin-like G-protein-coupled receptor family and is inhibited by a typical antipsychotic butyrophenone derivative known for its D2 receptor antagonism. This matches the description of the H1 receptor, which is a rhodopsin-like GPCR activated by histamine and involved in allergic responses.  Typical antipsychotics like haloperidol, which are butyrophenone derivatives, are known for their D2 receptor antagonism and use in treating schizophrenia. \nANSWER: H1 receptor </s>"}
{"custom_id": "Naproxen-Norfloxacin_3:zero_shot", "response": "REASON: The presence of a carbonyl group (C=O) in the propionic acid side chain of the first drug makes it a potential hydrogen bond acceptor. The second drug has a piperazine ring, which can act as a hydrogen bond donor, but not an acceptor.\nANSWER: the drug with a methoxy-substituted naphthalene ring and a propionic acid side chain \n"}
{"custom_id": "Naproxen-alendronic acid-Salmeterol-Beta-1 adrenergic receptor_8:zero_shot", "response": "REASON: The question describes a drug used for respiratory conditions and mentions a potential interaction with a bisphosphonate. Cholecystitis is a complication associated with bisphosphonates and certain drugs that affect bile acid metabolism. Albuterol, a common long-acting bronchodilator used for asthma and COPD, is known to cause cholecystitis when used with bisphosphonates. Albuterol acts via beta-2 adrenergic receptors, which are found in the lungs but also in cardiac tissue and the cerebral cortex. \nANSWER: beta-2 adrenergic receptor \n"}
{"custom_id": "Orphenadrine-Temazepam_3:zero_shot", "response": "REASON: The 1,4-benzodiazepin-2-one core is a structural feature of drugs like Xanax. Drugs containing a hydroxyl and a ketone group are known to participate in hydrogen bonding. \nANSWER: Xanax </s>"}
{"custom_id": "alendronic acid-Indapamide_3:zero_shot", "response": "REASON: The compound with the terminal primary amine on a butane backbone can act as a hydrogen bond donor due to the presence of the amine group which can donate a proton.\nANSWER: compound containing two phosphonic acid groups and a terminal primary amine on a butane backbone </s>"}
{"custom_id": "Fentanyl-Labetalol-Alpha-1B adrenergic receptor_7:zero_shot", "response": "REASON: The question describes a synthetic opioid agonist known for its potency and overdose risk, often used for severe pain. It also mentions an antihypertensive agent that blocks both \u03b2- and \u03b1-adrenergic receptors and is used for conditions like pregnancy-induced hypertension. The question focuses on the specific adrenergic receptor inhibited by the antihypertensive agent, whose structure has been studied with (+)-cyclazosin. (+)-cyclazosin is an inverse agonist at the \u03b12-adrenergic receptor. Thus, the antihypertensive agent targets the \u03b12-adrenergic receptor.\nANSWER: \u03b12-adrenergic receptor </s>"}
{"custom_id": "Naproxen-Lamotrigine-Zolpidem_1:zero_shot", "response": "REASON: The question describes a patient taking an anticonvulsant that modulates sodium and calcium channels, suggesting a drug like 'Lamotrigine'. It also mentions avoiding a short-acting hypnotic that enhances GABAA receptor-mediated inhibition due to its association with interstitial cystitis. 'Zolpidem' is a short-acting hypnotic known for enhancing GABAA receptor activity and has been linked to interstitial cystitis in combination with 'Lamotrigine'.\nANSWER: Zolpidem </s>"}
{"custom_id": "Lamotrigine-Salmeterol-Beta-3 adrenergic receptor_7:zero_shot", "response": "REASON: The question describes a medication used for asthma and COPD that binds and activates an adrenergic receptor encoded by the ADRB3 gene. ADRB3 encodes the beta-3 adrenergic receptor. \nANSWER: beta-3 adrenergic receptor </s>"}
{"custom_id": "Lamotrigine-Zaleplon_0:zero_shot", "response": "REASON: The question describes a drug used for seizure and bipolar disorder management and another for insomnia. The risk of inducing apoplexy is associated with a specific interaction between these drugs. \nANSWER: alprazolam </s>"}
{"custom_id": "alendronic acid-Alprazolam-Doxazosin-Alpha-1B adrenergic receptor_8:zero_shot", "response": "REASON: The drug's mechanism of action involves blocking a specific type of adrenergic receptor, leading to effects on blood pressure and urinary symptoms. The drug is also known to cause dizziness and hypotension, which are common side effects of medications targeting the autonomic nervous system.\nANSWER: alpha-1 adrenergic receptor </s>"}
{"custom_id": "Haloperidol-oxybutynin_0:zero_shot", "response": "REASON: The question describes a medication that antagonizes D2 receptors, a mechanism of action common in antipsychotics. It also mentions an anticholinergic agent used for overactive bladder. Combining these drugs can lead to an increase in intracranial pressure, potentially causing an apoplexy. \nANSWER: Risperidone </s>"}
{"custom_id": "Carvedilol-Ibuprofen-Midodrine_1:zero_shot", "response": "REASON: The question mentions that the patient is taking a nonselective beta-adrenergic blocker that also blocks alpha-1 receptors. This suggests the patient is taking a drug that can affect both alpha-1 adrenergic receptors and beta-adrenergic receptors. Out of the three agents mentioned, only the oral antihypotensive prodrug that acts as a selective alpha-1 agonist can interact with the NSAID to cause dry skin.\nANSWER: oral antihypotensive prodrug that acts as a selective alpha-1 agonist </s>"}
{"custom_id": "Carvedilol-Metolazone-Metoprolol-Alpha-2C adrenergic receptor_8:zero_shot", "response": "REASON: The question describes a drug that is a beta-blocker, clinically used for cardiovascular conditions. It also mentions that this drug inhibits a receptor encoded by the gene ADRA2C. \nANSWER: beta-2 adrenergic receptor \n"}
{"custom_id": "Fluorouracil-mitomycin C_3:zero_shot", "response": "REASON: The five-membered ring with two ketone groups and a fluorine substituent is more likely to act as a hydrogen bond donor due to the presence of the highly electronegative oxygen atoms in the carbonyl groups. These oxygen atoms can readily donate hydrogen bonds.\nANSWER: Five-membered ring with two ketone groups and a fluorine substituent </s>"}
{"custom_id": "Ziprasidone-Desloratadine_0:zero_shot", "response": "REASON: Tricyclic H1 inverse agonists can cause an increase in heart rate as a side effect. \nANSWER: Tricyclic H1 inverse agonist </s>"}
{"custom_id": "alendronic acid-Lamivudine-Metoprolol-Perphenazine_5:zero_shot", "response": "REASON: The question describes a specific drug with a detailed chemical structure and then mentions a class of drugs (beta-blockers) that also have a characteristic structure. The hydrogen bonding interaction is a key point connecting these two structures. \nANSWER: Prochlorperazine </s>"}
{"custom_id": "Cimetidine-Citalopram-nevirapine-oxybutynin_2:zero_shot", "response": "REASON: The question describes a scenario where a patient taking HIV medication experiences increased emesis (vomiting) after starting an additional medication for overactive bladder. It highlights that the second medication is an anticholinergic, a class of drugs known to cause side effects like xerostomia (dry mouth) and urinary retention. While these side effects are mentioned, the question focuses on the increased risk of emesis. Anticholinergics are not typically associated with emesis. Therefore, the emesis is likely due to an interaction with the HIV medication.  The question implies that the second medication is being added to the existing HIV therapy. Thus, the increased risk of emesis is likely associated with the second medication being added to the HIV treatment."}
{"custom_id": "Celecoxib-Midodrine_3:zero_shot", "response": "REASON: Both sulfonamide and secondary amine groups are capable of forming hydrogen bonds. The first drug contains a sulfonamide group, and the second drug contains a secondary amine group.\nANSWER: sulfonamide </s>"}
{"custom_id": "Metronidazole-Fosphenytoin_3:zero_shot", "response": "REASON: The nitroimidazole compound can act as a hydrogen bond donor through the nitrogen atom in the nitroimidazole ring. \nANSWER: nitroimidazole compound \n"}
{"custom_id": "Lamotrigine-Oxaprozin_3:zero_shot", "response": "REASON: The compound with a carboxylic acid group is capable of accepting a hydrogen bond.\nANSWER: phenylpropionic acid derivative \n"}
{"custom_id": "Candesartan-Perindopril_3:zero_shot", "response": "REASON: The drug with a perhydroindole core structure has two nitrogen atoms in the structure, while the drug with a tetrazole ring has only one. Thus, the perhydroindole core structure has more electron-rich nitrogen atoms and is more likely to act as a hydrogen bond acceptor. \nANSWER: perhydroindole core structure \n"}
{"custom_id": "Bumetanide-Ranolazine_3:zero_shot", "response": "REASON: Both drugs have functional groups capable of forming hydrogen bonds. The sulfonamide group and the hydroxyl group in the methoxyphenyl-ethanol side chain can act as hydrogen bond donors, while the nitrogen atoms in the piperazine ring and the chlorinated aromatic ring can act as hydrogen bond acceptors. \nANSWER: Sulfonamide drug \n"}
{"custom_id": "Methylphenidate-Ofloxacin-Imatinib_4:zero_shot", "response": "REASON: The question describes a complex molecular structure with specific functional groups. The presence of a piperazine ring, a fused pyrimidine-phenyl structure, and a fluoroquinolone derivative with a morpholine ring connected to a fluorinated aromatic system strongly suggests a specific drug class. \nANSWER: Levofloxacin </s>"}
{"custom_id": "Rofecoxib-Triazolam_0:zero_shot", "response": "REASON: The question describes a scenario where a triazolobenzodiazepine, a class of CNS depressants, is being used for insomnia. It then asks about a drug that, when taken with this medication, increases the risk of cholecystitis. Cholecystitis is often associated with the use of certain NSAIDs.  \nANSWER: ibuprofen </s>"}
{"custom_id": "Celecoxib-Labetalol_3:zero_shot", "response": "REASON: The sulfonamide group in the first drug and the secondary amine in the second drug are both capable of acting as hydrogen bond donors. However, the knowledge-graph triple describes an interaction where a hydrogen bond donor interacts with a hydroxybenzamide group. The hydroxybenzamide group has a hydroxyl group (-OH), which is a good hydrogen bond acceptor. Thus, the hydrogen bond donor in this interaction is the sulfonamide group of the first drug. \nANSWER: sulfonamide group in the first drug \n"}
{"custom_id": "indometacin-oxybutynin_3:zero_shot", "response": "REASON: The indoleacetic acid core with a para-chloro-benzoyl group and a methoxy substituent has a carboxylic acid group which is capable of acting as a hydrogen bond donor.\nANSWER: indoleacetic acid core with a para-chloro-benzoyl group and a methoxy substituent </s>"}
{"custom_id": "Famotidine-Pirbuterol_0:zero_shot", "response": "REASON: The question describes a scenario where a medication is used in conjunction with a specific type of inhaler for asthma. It then mentions an elevated cholesterol interaction risk. Short-acting \u03b22 adrenoreceptor agonists are bronchodilators commonly used in asthma inhalers. The question implies that a certain medication interacts with these agonists to increase cholesterol levels. \nANSWER: atorvastatin </s>"}
{"custom_id": "Ranitidine-Sibutramine-Zolpidem-vincristine_5:zero_shot", "response": "REASON: The question describes a steric clash between two distinct chemical structures. To identify the drug, we need to focus on the complexity mentioned, \"fused rings,\" and \"ester groups.\" These characteristics are common in many drugs. The clue lies in the description of the interacting compound with an \"imidazopyridine core\" and \"N,N-dimethylacetamide functionality.\" This specific combination strongly suggests a drug interaction. \nANSWER: <Xanax> \n"}
{"custom_id": "Fentanyl-Ketorolac-oxybutynin-Zaleplon_5:zero_shot", "response": "REASON: The question describes a specific drug with a pyrazolopyrimidine core and an N-ethylacetamide moiety, known to engage in pi-pi stacking interactions. This is a characteristic feature of interactions between small molecules and tertiary amine-containing compounds.\nANSWER: <drug name> \n"}
{"custom_id": "Labetalol-Metoprolol-Perphenazine-Alpha-2A adrenergic receptor_8:zero_shot", "response": "REASON: The question describes a drug with specific properties, including its potency relative to chlorpromazine, its target receptor, and a drug-drug interaction involving a beta-blocker. These properties match the profile of haloperidol. \nANSWER: Dopamine-2 receptor</s>"}
{"custom_id": "alendronic acid-Efavirenz-Lamivudine-Metoprolol_2:zero_shot", "response": "REASON: The question describes a patient taking a nucleoside reverse transcriptase inhibitor (NRTI), a class of drugs used to treat HIV. It also mentions the patient developed dysarthria (difficulty speaking) after starting a cardioselective \u03b21-adrenergic antagonist. This type of antagonist is commonly used for cardiovascular conditions. \nANSWER: Metoprolol </s>"}
{"custom_id": "Amlodipine-Rosiglitazone_0:zero_shot", "response": "REASON: The thiazolidinedione-class PPAR\u03b3 agonist is pioglitazone, and pioglitazone is known to interact with warfarin, increasing the risk of bleeding complications including apoplexy. \nANSWER: warfarin </s>"}
{"custom_id": "Fentanyl-Labetalol-Metoprolol-Pirbuterol_2:zero_shot", "response": "REASON: Beta-blockers can cause bronchospasm, which can be worsened by beta-2 agonists. Erythema is a possible side effect of bronchospasm. The question specifies that the inhaled medication is a short-acting beta-2 adrenoreceptor agonist. \nANSWER: short-acting \u03b22 adrenoreceptor agonist </s>"}
{"custom_id": "Bumetanide-Fenofibrate_0:zero_shot", "response": "REASON: PPAR\u03b1 agonists are known to increase the risk of hepatic neoplasia.\nANSWER: PPAR\u03b1 agonist </s>"}
{"custom_id": "Famotidine-Pilocarpine_3:zero_shot", "response": "REASON: The amidino group in the thiazole-containing drug is capable of acting as a hydrogen bond donor, while the carbonyl oxygen in the dihydrofuranone of the other drug is a common hydrogen bond acceptor.\nANSWER: dihydrofuranone fused to a methylated imidazole ring </s>"}
{"custom_id": "Fentanyl-Loxapine-Alpha-2C adrenergic receptor_7:zero_shot", "response": "REASON: The question describes a scenario involving drug interactions. It mentions a medication for schizophrenia that is metabolized into a tricyclic antidepressant, which can cause deglutition disorder when combined with a synthetic opioid analgesic. The question then asks about the specific adrenergic receptor targeted by the antipsychotic. \nKnowing that typical antipsychotics often block dopamine receptors and some adrenergic receptors, and that tricyclic antidepressants can affect multiple receptors, including adrenergic ones, we can pinpoint the likely receptor.\nANSWER: alpha-2 adrenergic receptor \n"}
{"custom_id": "Naproxen-Zolpidem_0:zero_shot", "response": "REASON: The question describes a nonbenzodiazepine hypnotic (a type of sleep medication) that interacts with a nonsteroidal anti-inflammatory agent (NSAID) in adenomyosis. This points to a specific drug class known for these interactions. \nANSWER: Zolpidem </s>"}
{"custom_id": "Furosemide-vincristine_0:zero_shot", "response": "REASON: The question mentions a loop diuretic interacting with a vinca alkaloid, leading to amyloidosis.  Loop diuretics like furosemide act on the Na-K-2Cl symporter. Vinca alkaloids like vincristine interfere with microtubule formation. However, the specific interaction leading to amyloidosis is not directly stated in the provided information. \nANSWER:  This question cannot be answered from the given context. \n"}
{"custom_id": "Ketorolac-Duloxetine_0:zero_shot", "response": "REASON: The question describes a medication that inhibits prostaglandin synthesis for pain relief. This is a characteristic of NSAIDs like ibuprofen or naproxen. Neuropathic pain is often treated with medications targeting serotonin and norepinephrine reuptake, like SNRIs. \nANSWER: Ibuprofen \n"}
{"custom_id": "Furosemide-hydralazine_3:zero_shot", "response": "REASON: The molecule with a phthalazine core and two hydrazine groups is more likely to act as a hydrogen bond acceptor. Hydrazine groups (NH2) are known to act as hydrogen bond acceptors due to the lone pair of electrons on the nitrogen atom.\nANSWER: phthalazine core featuring two hydrazine functional groups </s>"}
{"custom_id": "Diazepam-Desloratadine_3:zero_shot", "response": "REASON: The molecule with the seven-membered diazepine ring containing two nitrogen atoms is more likely to act as a \u03c0-acceptor. Diazepines are known to exhibit \u03c0-\u03c0 stacking interactions due to their planar structure and the presence of nitrogen atoms, which can donate electron density and participate in hydrogen bonding. The chlorinated benzene and pyridine rings in the tricyclic structure may not be as effective in \u03c0-\u03c0 stacking interactions.\nANSWER: Seven-membered diazepine ring with two nitrogen atoms fused to a benzene (bearing a chlorine) and attached to a phenyl group. \n"}
{"custom_id": "Haloperidol-indometacin-vincristine-Torasemide_5:zero_shot", "response": "REASON: The question describes a drug with specific structural features and its interaction with a large, multi-ringed indole-based anticancer agent. This suggests a drug-drug interaction. I need to identify a drug matching the described structure.\nANSWER: Imatinib </s>"}
{"custom_id": "Theophylline-Bumetanide-vincristine-Torasemide_5:zero_shot", "response": "REASON: The question describes a drug with specific structural features and its interaction with two other molecules. It mentions a \"sulfonamide-containing loop diuretic\" which is a known class of drugs. \nANSWER: hydrochlorothiazide </s>"}
{"custom_id": "Naproxen-Carvedilol_0:zero_shot", "response": "REASON: The question describes a drug that interacts with an NSAID to cause adenopathy. This is a known interaction between beta-blockers and NSAIDs. The question specifies that the beta-blocker is a nonselective beta-adrenergic blocker with alpha-1 receptor antagonism, further narrowing down the possibilities. \nANSWER: Metoprolol </s>"}
{"custom_id": "Diazepam-Temozolomide-Thalidomide_4:zero_shot", "response": "REASON: The question describes a complex tripartite hydrogen bonding network.  It mentions a \"benzodiazepine derivative possessing a chlorinated aromatic ring,\" which is a classic structural feature of drugs like Xanax.\nANSWER: Xanax \n"}
{"custom_id": "alendronic acid-Imatinib_3:zero_shot", "response": "REASON: The question describes a hydrogen bond interaction between two compounds. One compound has a terminal primary amine, which is a known hydrogen bond donor. The other compound has a piperazine moiety with a nitrogen atom that acts as a hydrogen bond acceptor. \nANSWER: piperazine-containing moiety </s>"}
{"custom_id": "Risedronic acid-Trazodone-Alpha-2C adrenergic receptor_7:zero_shot", "response": "REASON: The question describes a drug-drug interaction where a bisphosphonate and a sedating antidepressant may cause problems. It also states that the antidepressant binds to and inhibits a specific adrenergic receptor. We need to identify the antidepressant and its mechanism of action. \"Sedating antidepressant that is a serotonin antagonist and reuptake inhibitor\" points to drugs like Xanax (alprazolam), which are not selective serotonin reuptake inhibitors (SSRIs) but  have sedative effects.  SSRIs  block the reuptake of serotonin, increasing its effect in the brain. However, the question mentions inhibition of a specific adrenergic receptor. Among SSRIs,  Xanax is known to bind to and inhibit the"}
{"custom_id": "Rofecoxib-Zolpidem-vincristine-Torasemide_2:zero_shot", "response": "REASON: The question mentions a vinca alkaloid, a class of drugs known to interact with loop diuretics. \nANSWER: furosemide </s>"}
{"custom_id": "Candesartan-Fenofibrate-Modafinil-Bimatoprost_2:zero_shot", "response": "REASON: The question describes a drug interaction involving a central nervous system stimulant, an angiotensin receptor blocker, and an ophthalmic prostaglandin analog. It specifically asks for the medication implicated in the interaction, which is characterized by reversible eye color changes and used as an eye drop. This points to a prostaglandin analog used for glaucoma treatment.\nANSWER: bimatoprost </s>"}
{"custom_id": "Diazepam-Ofloxacin_0:zero_shot", "response": "REASON: The benzodiazepine anxiolytic acting at GABA_A receptors, namely **Xanax**, is associated with causing gastric inflammation when administered with the fluoroquinolone that inhibits bacterial DNA gyrase, **Ciprofloxacin**. This is because both drugs are known to inhibit gastric acid secretion, and when used together, they can lead to an imbalance in the stomach's acid-base environment, resulting in inflammation. \nANSWER: Xanax, Ciprofloxacin </s>"}
{"custom_id": "Pamidronic acid-thiotepa_3:zero_shot", "response": "REASON: The question describes the hydrogen bond donor in the interaction between two drugs. Among the two described drugs, the one with an aziridine-containing phosphorothioate core is more likely to act as a hydrogen bond donor.  Phosphorothioate groups can act as hydrogen bond donors.\nANSWER: aziridine-containing phosphorothioate core </s>"}
{"custom_id": "Cimetidine-Labetalol-Metoprolol-Prostacyclin receptor_8:zero_shot", "response": "REASON: The drug described is metoprolol, a beta-blocker. Beta-blockers activate beta-adrenergic receptors, which mediate vasodilation. \nANSWER: beta-2 adrenergic receptor \n"}
{"custom_id": "Naproxen-Furosemide-Zolpidem-vincristine_5:zero_shot", "response": "REASON: The indole-based scaffold with multiple methoxy groups and an ester side chain is characteristic of **Xanax**. The imidazo[1,2-a]pyridine core substituted with a tolyl group and a methylamide, hydrogen bonding with a benzene-fused five-membered sulfur-containing ring system bearing a carboxylic acid and sulfonamide, which in turn hydrogen bonds with a propionic acid derivative featuring a methoxy naphthalene motif, describes **alprazolam**. Alprazolam is known to have steric clashes with Xanax.\nANSWER: Xanax </s>"}
{"custom_id": "Fentanyl-vincristine_3:zero_shot", "response": "REASON: The compound with multiple fused rings and multiple methoxycarbonyl and indole motifs is more likely to experience steric hindrance. \nANSWER: Compound with multiple fused rings and multiple methoxycarbonyl and indole motifs \n"}
{"custom_id": "Diazepam-Temozolomide_3:zero_shot", "response": "REASON: The molecule featuring a fused benzodiazepine ring with a chlorine substituent on the aromatic ring and a methyl group attached to nitrogen has a nitrogen atom with a lone pair of electrons that can act as a hydrogen bond acceptor. The molecule containing an imidazotetrazine ring with two adjacent carbonyl groups and an amide has two carbonyl groups and an amide, both of which can act as hydrogen bond donors.\nANSWER: imidazotetrazine ring with two adjacent carbonyl groups and an amide </s>"}
{"custom_id": "Efavirenz-Lamivudine_0:zero_shot", "response": "REASON: The question describes an antiretroviral drug associated with gastric inflammation when used with its nucleoside counterpart. This suggests a non-nucleoside reverse transcriptase inhibitor (NNRTI) being the culprit, as these are known for potential gastric side effects.  The question also mentions contraindication in pregnancy for this specific antiretroviral.  \nANSWER: Efavirenz </s>"}
{"custom_id": "Aciclovir-Azelastine_0:zero_shot", "response": "REASON: The question mentions a potential interaction between a guanosine analogue antiviral agent and a second-generation H1 antagonist. It specifically asks about the drug associated with erythema upon co-administration. While guanosine analogues are known for nephrotoxicity and gastrointestinal discomfort, the question focuses on a different side effect - erythema. Among second-generation H1 antagonists, fexofenadine is commonly associated with erythema. \nANSWER: fexofenadine </s>"}
{"custom_id": "indometacin-Terazosin_0:zero_shot", "response": "REASON: Erythema is a common side effect of non-steroidal anti-inflammatory drugs (NSAIDs) when taken with alpha-1 blockers. The combination can increase blood pressure and lead to flushing, which can manifest as erythema. \nANSWER: ibuprofen </s>"}
{"custom_id": "Ofloxacin-Darunavir_3:zero_shot", "response": "REASON: The question describes a drug with a bicyclic ring fused to a piperazine ring, multiple fluorine and ketone functionalities, and engages in hydrogen bonding with a drug containing a sulfonamide-linked phenyl group and cyclic ether moieties. This specific structural description points towards a known drug interaction. \nANSWER: Carbamazepine - Sulfadiazine </s>"}
{"custom_id": "Fentanyl-Labetalol_0:zero_shot", "response": "REASON: The question highlights a drug's potency in managing severe pain through \u03bc-opioid receptor activation, suggesting it's suitable for treating a back injury. The other drug is primarily used for blood pressure control and adrenergic blockade, making it less likely to be chosen for pain management. \nANSWER: Oxycodone </s>"}
{"custom_id": "indometacin-Sildenafil_0:zero_shot", "response": "REASON: The question describes a drug that acts on PDE5, an enzyme involved in vasodilation. It also mentions a risk of apoplexy when interacting with a drug that inhibits prostaglandin synthesis. PDE5 inhibitors are commonly used to treat erectile dysfunction and pulmonary hypertension. The interaction with a COX inhibitor, like NSAIDs, can increase the risk of bleeding, which could lead to apoplexy. Therefore, the medication likely refers to a PDE5 inhibitor used for erectile dysfunction.\nANSWER: Sildenafil (Viagra) </s>"}
{"custom_id": "Citalopram-Propofol_0:zero_shot", "response": "REASON: The rapid-onset intravenous anesthetic mentioned in the question is likely Ketamine. Ketamine is known to interact with certain medications and can potentially contribute to cataract development. \nANSWER: Ketamine </s>"}
{"custom_id": "Triazolam-Rosiglitazone-Bimatoprost_4:zero_shot", "response": "REASON: The question describes a complex drug interaction involving hydrogen bonding and \u03c0-\u03c0 stacking.  The mention of \"dichlorinated triazolobenzodiazepine\" is a strong clue, as this is a common structural feature of benzodiazepines like Xanax. Benzodiazepines are known to interact with the GABA-A receptor, a protein involved in anxiety and sleep regulation. \nANSWER: Xanax \n"}
{"custom_id": "Naproxen-Gabapentin_0:zero_shot", "response": "REASON: The question describes a drug that increases gastric inflammation risk when taken with another drug targeting \u03b12\u03b4-1 subunit of voltage-gated calcium channels. This is a characteristic of non-selective COX inhibitors. The commonly prescribed agent for neuropathic pain binding to \u03b12\u03b4-1 is gabapentin. Thus, the medication associated with increased gastric inflammation is a non-selective COX inhibitor like ibuprofen. \nANSWER: ibuprofen \n"}
{"custom_id": "Duloxetine-Desloratadine_3:zero_shot", "response": "REASON: The drug with a thiophene ring connected via an ether linkage to a fused naphthalene system is more likely to act as a \u03c0-\u03c0 stacking donor. The naphthalene ring system contains a large, planar aromatic system that can participate in \u03c0-\u03c0 stacking interactions. \nANSWER: Thiophene ring connected via an ether linkage to a fused naphthalene system \n"}
{"custom_id": "Loxapine-Muscarinic acetylcholine receptor M4_6:zero_shot", "response": "REASON: The question describes a cholinergic receptor subtype (CHRM4) that is inhibited by a tricyclic antipsychotic medication similar to clozapine. This matches the description of the alpha-2 adrenergic receptor, which is a cholinergic receptor and is inhibited by tricyclic antipsychotics like imipramine. \nANSWER: alpha-2 adrenergic receptor"}
{"custom_id": "indometacin-vincristine-Torasemide_1:zero_shot", "response": "REASON: The vinca alkaloid disrupts microtubule assembly, which is necessary for cell division. Sulfonamide loop diuretics decrease sodium reabsorption, which can lead to low potassium levels.  Low potassium levels can increase the risk of cardiac arrhythmias, which can be exacerbated by the mitotic inhibitor. \nANSWER: sulfonamide loop diuretic </s>"}
{"custom_id": "Cimetidine-Duloxetine_3:zero_shot", "response": "REASON: Imidazole rings are known to participate in hydrogen bonding due to the presence of multiple nitrogen atoms. The sulfur and cyano substituents in the first drug molecule can further enhance its hydrogen bonding capability. Thiophene rings and ether linkages are also capable of participating in hydrogen bonding.\nANSWER: Drug containing an imidazole ring substituted with sulfur and cyano functionalities </s>"}
{"custom_id": "Amlodipine-Metolazone-Metoprolol-Gastrin-releasing peptide receptor_8:zero_shot", "response": "REASON: The question describes a protein found in the pancreas involved in hormone release and muscle contraction. It's activated by a specific type of beta-adrenergic antagonist used for cardiovascular conditions. This points towards the beta-adrenergic receptor in the pancreas. The question also mentions co-prescription with a thiazide diuretic, hinting at metolazone. Metolazone is a thiazide diuretic.\nANSWER: beta-2 adrenergic receptor, metolazone </s>"}
{"custom_id": "Gabapentin-Ibuprofen_0:zero_shot", "response": "REASON: The question describes a medication that modulates voltage-gated calcium channels, a mechanism relevant to drugs like gabapentin. It also mentions a cyclooxygenase inhibitor, a class of drugs including NSAIDs like ibuprofen.  Erythema is a common side effect of NSAIDs. The combination of these drug classes is known to increase the risk of skin reactions, including erythema. \nANSWER: gabapentin </s>"}
{"custom_id": "Furosemide-Salmeterol_3:zero_shot", "response": "REASON: The chlorinated benzene ring with a sulfonamide and carboxylic acid substituent attached via a methylene bridge has two potential hydrogen bond donors: the sulfonamide nitrogen and the carboxylic acid proton. The phenyl group tethered by a long aliphatic ether chain to a secondary amine connected to a catechol moiety has two potential hydrogen bond donors: the secondary amine nitrogen and the catechol hydroxyl groups. However, the catechol hydroxyl groups are more likely to act as hydrogen bond acceptors due to their high electronegativity and the presence of the electron-withdrawing catechol ring. Thus, the sulfonamide nitrogen of the chlorinated benzene ring is more likely to act as the hydrogen bond donor.\nANSWER: Sulfonamide nitrogen"}
{"custom_id": "Amlodipine-Sufentanil_0:zero_shot", "response": "REASON: Ultra-potent synthetic opioid analgesics can cause respiratory depression, which can lead to decreased cardiac output and increased right heart load, potentially leading to right heart failure in patients already at risk due to conditions like hypertension and medications that affect vasodilation. \nANSWER: Fentanyl </s>"}
{"custom_id": "Fentanyl-Trimethoprim_0:zero_shot", "response": "REASON: The question describes a medication that affects bacterial folate metabolism and causes dysarthria when combined with a potent opioid agonist. Sulfa drugs, like sulfamethoxazole, are known for their antibacterial properties targeting folate synthesis.  Opioid agonists, such as morphine, are commonly used for severe pain management.  The question implies a drug-drug interaction between a sulfa drug and a potent opioid.\nANSWER: sulfamethoxazole </s>"}
{"custom_id": "Tolbutamide-Perindopril_0:zero_shot", "response": "REASON: The question describes a drug that inhibits angiotensin II synthesis, a common mechanism of action for blood pressure medications. It also mentions a first-generation sulfonylurea, a type of diabetes medication that stimulates insulin secretion. Certain sulfonylureas are known to cause muscle disorders in combination with ACE inhibitors, which also inhibit angiotensin II synthesis. \nANSWER: Losartan </s>"}
{"custom_id": "Naproxen-Lamotrigine_3:zero_shot", "response": "REASON: The molecule with a carboxylic acid functionality can act as a hydrogen bond donor, as the carboxyl group (COOH) can donate a proton (H+) to form a hydrogen bond.\nANSWER: Carboxylic acid \n"}
{"custom_id": "Ibuprofen-desvenlafaxine_3:zero_shot", "response": "REASON: The carboxylic acid functional group (-COOH) is a well-known hydrogen bond acceptor due to the presence of the electronegative oxygen atom and its ability to form a stable hydrogen bond.  While the cyclohexanol ring can participate in hydrogen bonding, the presence of the dimethylaminoethyl phenol core, with its tertiary amine and phenolic hydroxyl group, makes it a stronger hydrogen bond donor. \nANSWER: Carboxylic acid"}
{"custom_id": "Candesartan-Citalopram_3:zero_shot", "response": "REASON: Biphenyl-tetrazole moieties are known to engage in \u03c0-\u03c0 stacking interactions.\nANSWER: Biphenyl-tetrazole moiety </s>"}
{"custom_id": "Amlodipine-Exemestane_0:zero_shot", "response": "REASON: The medication described is known for its calcium channel blocking action, a mechanism used to treat hypertension. Additionally, it is mentioned to cause pain when used alongside an aromatase inhibitor, a drug class used in hormone-receptor-positive breast cancer treatment. \nANSWER: Diltiazem \n"}
{"custom_id": "Ofloxacin-Imatinib_3:zero_shot", "response": "REASON: The question describes a drug interaction, and asks for the name of one of the drugs involved. It provides a detailed description of the chemical structure of one of the drugs. \nANSWER: <No answer> \n"}
{"custom_id": "Labetalol-Beta-3 adrenergic receptor_6:zero_shot", "response": "REASON: The question describes a receptor that is a beta-adrenergic receptor and is inhibited by a medication used to treat hypertension and angina. This matches the description of the alpha-2 adrenergic receptor.\nANSWER: alpha-2 adrenergic receptor </s>"}
{"custom_id": "Cimetidine-Histamine H2 receptor_6:zero_shot", "response": "REASON: The description of the protein's function (coupling to adenylate cyclase, Gs alpha subunit, cAMP production stimulation) points towards the Gs alpha subunit-coupled receptor family. Proton pumps (H+/K+ ATPases) in the parietal cells of the stomach are a key target for drugs that reduce stomach acid production. These pumps are regulated by Gs alpha subunit-coupled receptors. Thus, the protein targeted by the drug is the H+/K+ ATPase. \nANSWER: H+/K+ ATPase \n"}
{"custom_id": "chlortalidone-Sildenafil-Zaleplon_1:zero_shot", "response": "REASON: The question describes a drug used for erectile dysfunction and pulmonary arterial hypertension that inhibits phosphodiesterase type 5. It then mentions a sedative-hypnotic from the pyrazolopyrimidine class that interacts with this drug, leading to an increased risk of apoplexy. The drug known for its pyrazolopyrimidine structure and sedative-hypnotic properties is Alprazolam. \nANSWER: Alprazolam </s>"}
{"custom_id": "Cimetidine-Sumatriptan-Balsalazide_1:zero_shot", "response": "REASON: The question describes a disease-modifying antirheumatic drug that causes breathing difficulties when combined with a triptan. Triptans are serotonin receptor agonists, specifically targeting the 5-HT1B/1D subtype. The drug releasing 5-aminosalicylic acid in the large intestine is a key characteristic of this class of drugs. \nANSWER: Infliximab </s>"}
{"custom_id": "Cimetidine-Labetalol-Alpha-1D adrenergic receptor_7:zero_shot", "response": "REASON: The medication described blocks both \u03b2- and \u03b1-adrenergic receptors, indicating it interacts directly with these receptor proteins. The question specifically asks for the inhibited receptor. \nANSWER: \u03b1-2 adrenergic receptor \n"}
{"custom_id": "Famotidine-Ticlopidine_3:zero_shot", "response": "REASON: The question describes a drug with specific structural features and then asks about its interaction with another drug with equally specific structural features. This suggests a drug-drug interaction. \nANSWER: Sulfadiazine </s>"}
{"custom_id": "Naproxen-Cetirizine-Salmeterol_4:zero_shot", "response": "REASON: The question describes a molecular interaction between three compounds. It focuses on identifying the drug that acts as a hydrogen bond acceptor from the piperazine-containing molecule. Among the three compounds, the one with a phenylethanolamine framework and a long aliphatic chain is most likely to possess the necessary hydrogen bond donor group.\nANSWER:  Phenylethanolamine  \n"}
{"custom_id": "phenytoin-Dapsone-Pyrimethamine-Muscarinic acetylcholine receptor M1_8:zero_shot", "response": "REASON: The question describes a protozoal folic acid antagonist that inhibits a Gq protein-coupled receptor predominantly found in the CNS and exocrine glands.  This points to the metabotropic glutamate receptor 5 (mGluR5). mGluR5 is a Gq protein-coupled receptor found in the brain and other tissues, including exocrine glands. It is a target of protozoal folic acid antagonists like pyrimethamine. \nANSWER: metabotropic glutamate receptor 5 (mGluR5) \n"}
{"custom_id": "Ziprasidone-Desloratadine-Telithromycin_1:zero_shot", "response": "REASON: The tricyclic H1 inverse agonist is known to cause an increase in heart rate, and when combined with a ketolide antibiotic, it can increase the risk of sinus headache. \nANSWER: tricyclic H1 inverse agonist </s>"}
{"custom_id": "Naproxen-Carvedilol_3:zero_shot", "response": "REASON: The aryloxypropanol side chain in the second compound has a secondary hydroxyl group which can act as a hydrogen bond acceptor. While the naphthalene ring in the first compound has a methoxy substituent, it does not possess a group capable of acting as a hydrogen bond acceptor.\nANSWER: aryloxypropanol side chain"}
{"custom_id": "Candesartan-mitomycin C-vincristine-Torasemide_5:zero_shot", "response": "REASON: The question describes a drug with specific functional groups and mentions an alkaloid with indole and catharanthine moieties. This suggests a drug-alkaloid interaction. Searching for drugs with chlorobenzenesulfonamide, pyridine, urea, and alkaloid targets reveals that **codicine** fits the description. Codicine is an alkaloid itself, but it interacts with other drugs through hydrogen bonding. One such interaction involves a chlorobenzenesulfonamide-containing drug. \nANSWER: **codicine** \n"}
{"custom_id": "Gabapentin-Amiloride_0:zero_shot", "response": "REASON: The second agent, a potassium-sparing diuretic, can cause weight gain as a side effect. This is due to its action on epithelial sodium channels, which leads to sodium and water retention in the body.\nANSWER: potassium-sparing diuretic </s>"}
{"custom_id": "Fentanyl-Trazodone_3:zero_shot", "response": "REASON: The piperidine ring in the first drug features a nitrogen atom. Nitrogen is capable of acting as a hydrogen bond acceptor. The triazolopyridine core in the second drug also contains a nitrogen atom capable of acting as a hydrogen bond acceptor. However, the chlorophenyl group in the second drug is more likely to act as a hydrogen bond donor. Thus, the piperidine ring in the first drug is more likely to act as the hydrogen bond acceptor. \nANSWER:  the one featuring a piperidine ring connected to a phenethyl group and a propionyl substituent \n"}
{"custom_id": "Lidocaine-vincristine-Torasemide_4:zero_shot", "response": "REASON: The question describes a complex interaction involving three entities. While it provides details about each entity, it primarily focuses on the hydrogen bonding interactions between the drug and the two other molecules. Identifying the drug based on its chemical structure and the mentioned interactions allows us to pinpoint the answer. \nANSWER: Apomorphine </s>"}
{"custom_id": "Carvedilol-Dobutamine_0:zero_shot", "response": "REASON: The question describes a scenario where a nonselective beta-blocker with alpha-1 antagonism is interacting with a synthetic \u03b21-adrenergic agonist. This combination is relevant to heart failure treatment. The question specifically points out a drug-drug interaction involving hepatitis when co-administered with the agonist.  Knowing the specific drug names and their mechanism of action will help identify the interaction. \nANSWER: carvedilol </s>"}
{"custom_id": "Citalopram-Zolpidem_0:zero_shot", "response": "REASON: The question describes a scenario where a chiral bicyclic phthalane derivative SSRI, a type of medication for depression, and a nonbenzodiazepine Z-drug sleep aid are interacting, causing adenopathy. The question asks for the name of the Z-drug that is primarily prescribed for short-term insomnia management. \nANSWER: Zolpidem </s>"}
{"custom_id": "Fentanyl-Labetalol-Alpha-2A adrenergic receptor_7:zero_shot", "response": "REASON: The question describes a drug that blocks both \u03b2- and \u03b1-adrenergic receptors and is used to treat hypertension. This is a classic description of prazosin, an antihypertensive medication. The receptor targeted by prazosin is involved in adrenergic signaling. \nANSWER: alpha-2 adrenergic receptor \n"}
{"custom_id": "Fluorouracil-Fulvestrant_3:zero_shot", "response": "REASON: The fluorinated pyrimidine with adjacent carbonyl and amide groups has multiple sites for hydrogen bond donation (carbonyl oxygen, amide nitrogen) while the steroidal molecule has limited hydrogen bond donor sites (phenolic hydroxyl, sulfonyl oxygen). Thus, the fluorinated pyrimidine is more likely to be the primary hydrogen bond donor.\nANSWER: fluorinated pyrimidine </s>"}
{"custom_id": "Zolpidem-vincristine_3:zero_shot", "response": "REASON: The drug with the large, multi-ringed structure and multiple substituents (methoxy ester and indole moieties) is more likely to experience steric clashes due to its greater volume and complex shape. \nANSWER: The drug characterized by a large, multi-ringed structure with several methoxy ester and indole moieties. \n"}
{"custom_id": "Cimetidine-hydroxychloroquine_3:zero_shot", "response": "REASON: The provided drug description matches the structure of Loratadine, an antihistamine. Histamine H2 receptor antagonists, like Ranitidine, possess a guanidine group and a cyano functional group, allowing them to form hydrogen bonds with Loratadine. \nANSWER: Loratadine </s>"}
{"custom_id": "Naproxen-Zolpidem-vincristine-Torasemide_5:zero_shot", "response": "REASON: The question describes a drug with specific structural features (phenyl-substituted pyridine ring with a sulfonylurea group) and a target molecule with indole and catharanthine rings. These structural features suggest a potential drug-target interaction. \nANSWER: Glimepiride </s>"}
{"custom_id": "Citalopram-Isoniazid-Emtricitabine_4:zero_shot", "response": "REASON: The question describes a specific molecular structure with key functional groups. It then asks for a compound that interacts with this structure via hydrogen bonding. Focusing on the \"sulfur-containing oxathiolane ring\" and \"fluorinated pyrimidine base,\" which are quite unique, and the \"hydrazide-substituted pyridine ring\" that forms hydrogen bonds with both, we can pinpoint a likely candidate. \nANSWER: Imatinib </s>"}
{"custom_id": "Carbachol-Muscarinic acetylcholine receptor M5_6:zero_shot", "response": "REASON: The question describes a cholinomimetic drug used in ophthalmic solutions. This points towards muscarinic acetylcholine receptors, which are part of the G protein-coupled receptor family. The question also mentions an extremely hazardous substance when overdosed, which is a characteristic of atropine, a potent muscarinic antagonist. However, the question asks for the receptor, not the antagonist. Thus, the answer is the muscarinic acetylcholine receptor. \nANSWER: Muscarinic acetylcholine receptor \n"}
{"custom_id": "acetazolamide-Haloperidol-Rosiglitazone-Bimatoprost_2:zero_shot", "response": "REASON: The question mentions a PPAR\u03b3 agonist, which is a class of drugs known to cause adenopathy. The ophthalmic medication mentioned is not specified, but any medication that increases the risk of adenopathy could potentially interact with the PPAR\u03b3 agonist.\nANSWER: PPAR\u03b3 agonist \n"}
{"custom_id": "Naproxen-alendronic acid_0:zero_shot", "response": "REASON: The medication described is a nonsteroidal anti-inflammatory drug (NSAID), which are known to inhibit COX enzymes and are used for pain and inflammation management. Combining NSAIDs with bisphosphonates can increase the risk of gastric inflammation. \nANSWER: NSAID </s>"}
{"custom_id": "Aciclovir-Doxazosin-Alpha-1B adrenergic receptor_7:zero_shot", "response": "REASON: The question describes a drug used to manage hypertension and benign prostatic hyperplasia, which is selective for and inhibits a receptor involved in adrenergic responses encoded by the ADRA1B gene.  The ADRA1B gene encodes the alpha-1A adrenergic receptor.\nANSWER: alpha-1A adrenergic receptor </s>"}
{"custom_id": "Risedronic acid-Zolpidem_3:zero_shot", "response": "REASON: Both drugs possess functional groups capable of hydrogen bonding. The pyridine ring with phosphonic acid groups in drug 1 can act as a hydrogen bond acceptor. Drug 2, with its imidazo[1,2-a]pyridine core and terminal amide, can act as a hydrogen bond donor. \nANSWER: Drug 1 \n"}
{"custom_id": "Amlodipine-vincristine_0:zero_shot", "response": "REASON: The drug described is **Vincristine**, and it is known to cause neutropenia (low white blood cell count). Dihydropyridine calcium channel blockers, like **Nifedipine**, can cause leukocytosis (increased white blood cell count). \nANSWER: Vincristine, Nifedipine </s>"}
{"custom_id": "Temazepam-Trimipramine-Histamine H1 receptor_7:zero_shot", "response": "REASON: The question describes a tricyclic antidepressant that inhibits a G-protein-coupled receptor involved in anti-allergy responses. This receptor is found in smooth muscle, vascular endothelium, and the central nervous system. Additionally, the question mentions that this antidepressant causes additive constipation when combined with a benzodiazepine.  The classic tricyclic antidepressant that fits this description is Amitriptyline. Amitriptyline is known to cause constipation.  The G-protein-coupled receptor that Amitriptyline inhibits is the H1 receptor, which is involved in anti-allergy responses. \nANSWER: H1 receptor </s>"}
{"custom_id": "Naproxen-Risedronic acid-vincristine-Torasemide_2:zero_shot", "response": "REASON: Sulfonamide loop diuretics can increase potassium levels in the body. Vinca alkaloids can cause hyperkalemia.  \nANSWER: Potassium\n"}
{"custom_id": "Duloxetine-desvenlafaxine_3:zero_shot", "response": "REASON: The molecule with the fused benzothiophene moiety linked via an ether bond to an N-methylpropanamine chain is more likely to act as the hydrogen bond donor due to the presence of the N-methylpropanamine group, which has a nitrogen atom capable of donating a hydrogen bond. \nANSWER: N-methylpropanamine chain"}
{"custom_id": "Aciclovir-Dipyridamole_0:zero_shot", "response": "REASON: The question describes a drug known for its antiviral action against herpesviruses and the risk of gastrointestinal side effects. It also states that this drug might cause skin eruptions when taken with another drug, a nucleoside transport and PDE3 inhibitor that acts as an antiplatelet agent and vasodilator. The first drug matches the description of 'Acyclovir'. The second drug matches the description of 'Pradaxa'. \nANSWER: Acyclovir \n"}
{"custom_id": "Celecoxib-Palonosetron_0:zero_shot", "response": "REASON: The question describes a drug used for inflammation and pain management that, when combined with a 5-HT3 antagonist, increases the risk of cellulitis. This matches the known interaction between Celecoxib (a COX-2 inhibitor) and 5-HT3 antagonists like ondansetron. \nANSWER: Celecoxib \n"}
{"custom_id": "Methylphenidate-Modafinil-Pamidronic acid-thiotepa_5:zero_shot", "response": "REASON: The question describes a complex molecular interaction involving hydrogen bonding and \u03c0-\u03c0 stacking. The mention of \"phosphorothioate,\" \"aziridine rings,\" \"phosphonic acid groups,\" and \"sulfinyl\" provides specific chemical clues. Searching for interactions involving these features suggests a likely match. \nANSWER: Sildenafil (Viagra) </s>"}
{"custom_id": "Desloratadine-solifenacin_0:zero_shot", "response": "REASON: The question describes two drugs: a tricyclic H1 inverse agonist used for allergies and an active metabolite of loratadine, and an oral antimuscarinic agent used to reduce bladder contractions. It also mentions that these drugs are associated with bursitis when they interact with each other. \nLet's analyze the information:\n* Tricyclic H1 inverse agonist used for allergies and an active metabolite of loratadine: This points towards **cetirizine**.\n* Oral antimuscarinic agent used to reduce bladder contractions: This is a classic description of **oxybutynin**.\n* Bursitis as part of the interaction: This is a known side effect of **cetirizine** when used with **"}
{"custom_id": "Naproxen-hydroxychloroquine_3:zero_shot", "response": "REASON: The carboxylic acid group on the naphthalene ring can act as a hydrogen bond donor, while the secondary amine on the quinoline ring can act as a hydrogen bond acceptor.\nANSWER: <drug featuring a carboxylic acid functional group attached to a naphthalene ring system> \n"}
{"custom_id": "Citalopram-Fenofibrate_0:zero_shot", "response": "REASON: The question describes two drugs: a selective serotonin reuptake inhibitor (SSRI) and a PPAR\u03b1 agonist. Certain combinations of SSRIs and PPAR\u03b1 agonists have been linked to an increased risk of cholecystitis. \nANSWER: PPAR\u03b1 agonist \n"}
{"custom_id": "Telmisartan-Cinacalcet_0:zero_shot", "response": "REASON: The question describes a scenario where two drugs are administered concurrently, and one of them is known to cause dysarthria in interaction with the other. The first drug is an angiotensin II receptor antagonist used for hypertension and heart failure. The second drug is an allosteric activator of the calcium-sensing receptor used for hyperparathyroidism. Dysarthria is a condition that affects speech and is often caused by neurological problems. Thinking about the neurological effects of the two drugs, the calcium-sensing receptor activator is more likely to cause dysarthria when interacting with the angiotensin II receptor antagonist. This is because the calcium-sensing receptor is involved in neuronal signaling pathways, and its activation can lead to changes in calcium homeostasis within"}
{"custom_id": "Rofecoxib-Torasemide_3:zero_shot", "response": "REASON: The sulfonamide group (-SO2NH-) is a well-known hydrogen bond donor, while the furanone and pyridine rings, although capable of hydrogen bonding, are less likely to act as donors in this specific context. \nANSWER: sulfonamide group \n"}
{"custom_id": "Lamotrigine-Dexpramipexole_3:zero_shot", "response": "REASON: The presence of a primary amine group in the propylamino-tetrahydrobenzothiazine structure allows it to act as a hydrogen bond donor by donating a proton to a hydrogen atom of another molecule.  Dichlorophenyl ring and triazine-2,4-diamine scaffold lack such a group.\nANSWER: propylamino-tetrahydrobenzothiazine structure with a primary amine \n"}
{"custom_id": "Alprazolam-Doxazosin_0:zero_shot", "response": "REASON: The question describes a drug that acts on the GABA_A receptor and is implicated in myelodysplasia when combined with an \u03b11-adrenergic blocker. This is a classic description of **Xanax** (alprazolam).\nANSWER: Xanax </s>"}
{"custom_id": "Ciclopirox-hydroxychloroquine_0:zero_shot", "response": "REASON: The drug mentioned in the question is known for its immunosuppressive properties, which can increase the risk of lymph node enlargement (adenopathy) when combined with another immunosuppressant like a topical antifungal. \nANSWER: Chloroquine </s>"}
{"custom_id": "alendronic acid-Ibuprofen_3:zero_shot", "response": "REASON: The question describes a drug with two phosphonic acid groups, which are known to participate in hydrogen bonding. It then mentions another drug with a carboxylic acid group, another common hydrogen bond donor. The presence of an isobutylbenzene core is less relevant to the hydrogen bonding interaction. \nANSWER: Fosaprepitant </s>"}
{"custom_id": "Celecoxib-Labetalol-Metoprolol-Gastrin-releasing peptide receptor_8:zero_shot", "response": "REASON: The question describes a protein highly expressed in the pancreas, involved in gastrointestinal hormones and cell proliferation. It's directly activated by a cardioselective \u03b21-adrenergic receptor antagonist used for angina and hypertension. The drug's metabolism is influenced by CYP2D6 variability. These characteristics point to the protein being the pancreatic beta-cell and the drug being Metoprolol. \nANSWER: pancreatic beta-cell, Metoprolol \n"}
{"custom_id": "Duloxetine-Darunavir_0:zero_shot", "response": "REASON: The question describes a drug that increases the risk of narcolepsy when co-administered with a specific HIV protease inhibitor. This protease inhibitor requires pharmacokinetic boosting, implying it has low bioavailability. The drug causing this interaction is known for its sedative effects, which contribute to narcolepsy. \nANSWER: Midazolam </s>"}
{"custom_id": "Minoxidil-Perindopril_3:zero_shot", "response": "REASON: The presence of multiple amine groups in the piperidine ring of the first compound provides more opportunities for hydrogen bond donation. Although the second compound also possesses amine groups, they are part of the perhydroindole skeleton and are less likely to act as hydrogen bond acceptors due to their proximity to the carboxylic acid and ester functionalities. These carboxylic acid and ester functionalities are more likely to act as hydrogen bond donors.\nANSWER: The first compound with the piperidine ring and pyrimidinone moiety. \n"}
{"custom_id": "Oxaprozin-Sildenafil_3:zero_shot", "response": "REASON: The description of the drug mentions \"fused benzoxazole core\" and \"biaryl structure,\" which are known to participate in \u03c0-\u03c0 stacking interactions. The description of the compound mentions \"pyrazolopyrimidinone scaffold\" and \"sulfonamide-substituted piperazine ring,\" which can also engage in \u03c0-\u03c0 stacking. \nANSWER: <Unlabeled entity> \n"}
{"custom_id": "Ibuprofen-Repaglinide_3:zero_shot", "response": "REASON: The presence of a carboxylic acid group (-COOH) allows for hydrogen bond donation (acting as a donor) and the presence of an amide group (-CONH2) allows for hydrogen bond acceptance (acting as an acceptor). Although both structures contain benzene rings, the presence of the carboxylic acid in the first drug makes it more likely to act as the hydrogen bond donor. \nANSWER: Propionic acid moiety attached to a benzene ring \n"}
{"custom_id": "Trazodone-Alpha-2C adrenergic receptor_6:zero_shot", "response": "REASON: The question describes a drug (phenylpiperazine) that inhibits a specific receptor (alpha-2 adrenergic receptor). The receptor is encoded by a human gene and involved in treating depression, anxiety, and insomnia.  Phenylpiperazines are known to act on alpha-2 adrenergic receptors. \nANSWER: alpha-2 adrenergic receptor </s>"}
